In the reversing reperfusion stroke, after 60 min, mRNA expression studies at 1 and 24 h reperfusion time provided strongly elevated (Egr1, Akt1, Kras, Src, Foxo, Srf, Vegfr2, NOS-3, and NOS-1) and decreased (NOS-2, Nfkb) gene expression (Mapk1 not activated) in rats that received BPC 157 therapy following reperfusion, as a way of showing how BPC 157 may act [145]
Some of this work reached early human investigation: full-length Thymosin Beta-4 has been examined in clinical-stage research for indications such as dry-eye disease and wound healing, which gives TB-500's parent compound a somewhat broader human-research footprint than BPC-157 although the synthetic TB-500 fragment itself remains a research compound without approval
Do you need larger doses, or are you working with micro-doses
Peptide and NAD+ Influencers While there are many influential voices, the people most associated with promoting peptides, and the ones they are linked with, are summarized in the Table below (generated by Deep Research)